Schroeder, M. C., Viyyuri, B. R., McDougall, D., Phadke, S. D., Charlson, J. A., Estrada-Merly, N., Chapman, C. G., Neuner, J. M. (2025). Neoadjuvant carboplatin/taxane (CbT) with or without doxorubicin/cyclophosphamide (AC) in real-world patients with early triple negative breast cancer (TNBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e23347